Henry Schein | HSIC - Srodki Pieniężne I Ekwiwalent

Cena Akcji
76.11
Dzienna Zmiana
-1.09 -1.41%
Miesięcznie
4.69%
Rocznie
15.04%
Q2 Prognozy TE
75.88




Srodki Pieniężne I Ekwiwalent Zmiana Data
Agilent USD 1.76B 31M 2025-12
Align Technology USD 1B 103.43M 2025-09
Bruker USD 293.1M 201.1M 2025-09
Cardinal Health USD 2.78B 1.82B 2025-12
Charles River Laboratories USD 213.77M 6.67M 2025-12
Cigna USD 7.68B 1.65B 2025-12
Concord Medical Services Hldg CNY 243.38M 85.1M 2023-06
Cooper Companies USD 110.6M 14.3M 2025-09
CVS Health USD 8.45B 645M 2025-12
Danaher USD 5.7B 1.09B 2026-03
Dentsply International USD 326M 37M 2025-12
Encompass Health USD 72.2M 23.5M 2025-12
Henry Schein USD 136M 9M 2025-09
Idexx Laboratories USD 180.07M 28.1M 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Laboratory Of America USD 532.3M 65.8M 2025-12
McKesson USD 2.96B 1.05B 2025-12
Mettler Toledo International USD 69.06M 7.24M 2025-09
Owens Minor USD 281.99M 249.15M 2025-12
Quest Diagnostics USD 393M 27M 2026-03
Revvity USD 919.86M 11.53M 2025-12
Stryker USD 4.01B 755M 2025-12
Tenet Healthcare USD 2.88B 92M 2025-12
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Universal Health Services USD 119.03M 18.77M 2026-03
Veradigm USD 492.6M 7.57M 2022-09
Waters USD 587.83M 128.71M 2025-12
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12
Zoetis USD 2.08B 649M 2025-09